Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05955378 · ClinicalTrials.gov registry record · NA

Assessing the DSR Ankle

A NA study of Amputation and Limb Deficiencies, sponsored by Synchro Motion.

Completed
Registry status
NA
Development phase
5
Enrollment target
1
Study location

NCT05955378: Completed NA study of Amputation and Limb Deficiencies, sponsored by Synchro Motion.

NCT05955378 is a NA study of Amputation and Limb Deficiencies that has completed, run by Synchro Motion. The registered enrollment target is 5 participants, below the 133-participant average among 65 other Amputation trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05955378, a NA study of Amputation and Limb Deficiencies, has completed, sponsored by Synchro Motion.

COMPLETED
Registry status
NA
Development phase
5 participants
Enrollment target
1
Study location

Study Summary

This research is being done to conduct a preliminary investigation into a new prosthetic microprocessor controlled (MPC) ankle, called the Damping, Stiffness, and Repositioning (DSR) ankle. The DSR ankle is a new design to support a person while they walk on both even and uneven ground, as well as with bending the ankle for safe foot clearance while a person takes a step. In particular, in this study we are interested in seeing how this type of new device may benefit people who are rated as a K2-level ambulator.

Primary Outcome

Minimum foot clearance is the shortest distance between the foot and the ground during swing, and it occurs approximately halfway through the swing phase of gait.

Interventions

  • DEVICE DSR Ankle
  • DEVICE Predicate Ankle

Study Locations (1)

Illinois

  • Shirley Ryan AbilityLab - Chicago

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2023-08-22
Est. Completion 2024-12-19
Phase NA
Synchro Motion

1 total trials

What the finished NCT05955378 record still lists

NCT05955378 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 133-participant average among 65 other Amputation trials with a reported enrollment target (96% lower).

The record links to 2 conditions, with Amputation appearing as the primary indexed condition, and to 2 interventions - of which DSR Ankle is the first listed.

NCT05955378 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT05955378 about?

NCT05955378 is a clinical study titled "Assessing the DSR Ankle". This research is being done to conduct a preliminary investigation into a new prosthetic microprocessor controlled (MPC) ankle, called the Damping, Stiffness, and Repositioning (DSR) ankle. The DSR ankle is a new design to support a person while they walk on both even and uneven ground, as well as w...

What is the current status of trial NCT05955378?

This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2023-08-22. Estimated completion is 2024-12-19.

What conditions does trial NCT05955378 study?

This clinical trial studies the following conditions: Amputation, Limb Deficiencies.

What interventions are being tested in trial NCT05955378?

The interventions under investigation include: DSR Ankle (DEVICE), Predicate Ankle (DEVICE).

Who is sponsoring clinical trial NCT05955378?

This trial is sponsored by Synchro Motion, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05955378 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amputation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05955378's enrollment target sits among peer trials

5 59th of 65 higher than 4 of 65 other Amputation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Amputation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05955378, the US trial registry maintained by the National Library of Medicine. NCT05955378 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.